Literature DB >> 10985487

Poly(D,L-lactide/epsilon-caprolactone)/hydroxyapatite composites.

E Ural1, K Kesenci, L Fambri, C Migliaresi, E Piskin.   

Abstract

In this study, elastomeric D,L-lactide and epsilon-caprolactone copolymers with two different molecular weights (Mn: 108.000 and 40.000) were synthesized by ring-opening polymerization of the respective dimers by using stannous octoate as the catalyst, as a potential bone-filling material. The final ratio of D,L-lactide to epsilon-caprolactone obtained by 1NMR was 60/40 (comparing to the initial ratio of 50/50). Both copolymers were amorphous having Tg at around -21 degrees C. Different amounts of hydroxyapatite (HA) powder were loaded within the copolymers. These composites were easily shaped by hand. Mechanical properties of the composites changed with the HA loading and the molecular weight of the copolymer. The percent elongation decreased, while both the Young's modulus and yield point (stress) increased with the HA content. The copolymers were degraded within the Ringer solutions in about 6 weeks. The molecular weight distribution became broader during degradation. Incorporation of HA reduced the degradation rate.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10985487     DOI: 10.1016/s0142-9612(00)00098-3

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  15 in total

1.  Novel starch thermoplastic/Bioglass composites: mechanical properties, degradation behavior and in-vitro bioactivity.

Authors:  I B Leonor; R A Sousa; A M Cunha; R L Reis; Z P Zhong; D Greenspan
Journal:  J Mater Sci Mater Med       Date:  2002-10       Impact factor: 3.896

2.  Treatment of segmental bone defects in rats by the stimulation of bone marrow osteo-progenitor cells with prostaglandin E2.

Authors:  A M Ozturk; E Cila; U Kanatli; I Isik; A Senkoylu; D Uzunok; E Piskin
Journal:  Int Orthop       Date:  2005-02-10       Impact factor: 3.075

3.  Osteogenic differentiation of mesenchymal progenitor cells in computer designed fibrin-polymer-ceramic scaffolds manufactured by fused deposition modeling.

Authors:  Jan-Thorsten Schantz; Arthur Brandwood; Dietmar Werner Hutmacher; Hwei Ling Khor; Katharina Bittner
Journal:  J Mater Sci Mater Med       Date:  2005-09       Impact factor: 3.896

4.  Enhancing growth and proliferation of human gingival fibroblasts on chitosan grafted poly (epsilon-caprolactone) films is influenced by nano-roughness chitosan surfaces.

Authors:  Tze-Wen Chung; Shoei-Shen Wang; Yen-Zen Wang; Chien-Hung Hsieh; Earl Fu
Journal:  J Mater Sci Mater Med       Date:  2008-09-25       Impact factor: 3.896

Review 5.  Biocomposites and hybrid biomaterials based on calcium orthophosphates.

Authors:  Sergey V Dorozhkin
Journal:  Biomatter       Date:  2011 Jul-Sep

6.  Studies on Poly(propylene fumarate-co-caprolactone diol) Thermoset Composites towards the Development of Biodegradable Bone Fixation Devices.

Authors:  M Jayabalan
Journal:  Int J Biomater       Date:  2009-02-25

7.  Preparation and characterization of hydroxyapatite/polycaprolactone-chitosan composites.

Authors:  Xiufeng Xiao; Rongfang Liu; Qiongyu Huang; Xiaohong Ding
Journal:  J Mater Sci Mater Med       Date:  2009-12       Impact factor: 3.896

Review 8.  Calcium Orthophosphate-Containing Biocomposites and Hybrid Biomaterials for Biomedical Applications.

Authors:  Sergey V Dorozhkin
Journal:  J Funct Biomater       Date:  2015-08-07

9.  Degradable phosphate glass fiber reinforced polymer matrices: mechanical properties and cell response.

Authors:  Delia S Brauer; Christian Rüssel; Sebastian Vogt; Jürgen Weisser; Matthias Schnabelrauch
Journal:  J Mater Sci Mater Med       Date:  2007-06-21       Impact factor: 3.896

10.  In vitro and in vivo evaluation of the biocompatibility of a calcium phosphate/poly(lactic-co-glycolic acid) composite.

Authors:  A Gala-García; M B H Carneiro; G A B Silva; L S Ferreira; L Q Vieira; M M Marques; R D Sinisterra; M E Cortes
Journal:  J Mater Sci Mater Med       Date:  2012-05-09       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.